Nat Protoc 15(2):668693
Janku F, Zhang S, Waters J, Liu L, Huang H, Subbiah V, Hong DS, Karp D, Fu S, Cai X, Ramzanali NM, Madwani K, Cabrilo G, Andrews DD, Zhao Y, Javle M, Kopetz S , Luthra R, Kim HJ, Gnerre S, Satya RV, Chuang HY, Kruglyak KM, Toung J, Zhao C, Shen R, Heymach J, Meric-Bernstam F, Mills GB, Fan JB, Salathia NS
The starting dose of probenicid is usually 250 mg twice daily but it may need to be increased to up to 1 g twice daily
Cellular Signaling & Healing Cascade BPC-157 activates angiogenesis (new blood vessel formation), upregulates growth hormone receptors in tendons and muscles, modulates the nitric oxide system to reduce inflammation, stimulates fibroblast activity for collagen production, and downregulates pro-inflammatory cytokines (TNF-, IL-6)
Human clinical trial data for Dihexa remain limited